false 0001191070 BIONOMICS LIMITED/FI 00-0000000 AU 0001191070 2024-10-09 2024-10-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

  

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 9, 2024

 

BIONOMICS LIMITED

(Exact name of registrant as specified in its charter)

 

Australia   001-41157   N/A
(State or other jurisdiction   (Commission File Number)   (IRS Employer
of incorporation)       Identification No.)

 

200 Greenhill Road
Eastwood, SA

Australia

   5063
(Address of principal executive offices)   (Zip Code)

 

+61 8 8150 7400

(Registrant’s telephone number, including area code)

 

N/A

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
American Depositary Shares   BNOX   The Nasdaq Global Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On October 9, 2024, Mr. Aaron Weaver, a member of the Board of Directors of Bionomics Limited (the “Company”), provided the Company’s board with notice that he was resigning from the Board of Directors, effective October 9, 2024. Mr. Weaver’s resignation does not involve any disagreement on any matter relating to the Company’s operations, policies or practices.

 

The Company thanks Mr. Weaver for his four years of service on the Company’s Board of Directors, and wishes him well in all future endeavors.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BIONOMICS LIMITED
   
Date: October 10, 2024 By: /s/ Spyridon Papapetropoulos
    Spyridon Papapetropoulos 
President and Chief Executive Officer

 

 

 

 

 

 

v3.24.3
Cover
Oct. 09, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 09, 2024
Entity File Number 001-41157
Entity Registrant Name BIONOMICS LIMITED/FI
Entity Central Index Key 0001191070
Entity Tax Identification Number 00-0000000
Entity Incorporation, State or Country Code C3
Entity Address, Address Line One 200 Greenhill Road
Entity Address, City or Town Eastwood, SA
Entity Address, Country AU
Entity Address, Postal Zip Code 5063
City Area Code +61
Local Phone Number 8 8150 7400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security American Depositary Shares
Trading Symbol BNOX
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Bionomics (NASDAQ:BNOX)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Bionomics.
Bionomics (NASDAQ:BNOX)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Bionomics.